Dear Editor, We report a case of acute megakaryoblastic leukemia French-American-British classification M7 (AML FAB-M7), a rare form of leukemia in the late post-transplantation period, which occurred in a patient 15 years after kidney transplantation. A 42-year-old man presented severely disabled (Karnofsky score 30) with fever of unknown origin and pancytopenia. He complained of weakness, loss of appetite, and elevated temperature for several days, ranging from 38°C to 40°C. The patient had been transplanted with a cadaveric kidney 15 years earlier. The cause of end-stage renal disease was unknown. No episodes of acute rejection had occurred in the post-transplant period. There was a slow progressive loss of renal function; a renal transplant biopsy obtained 1 year earlier showed a pronounced chronic allograft nephropathy with a severe arteriolohyalinosis but no signs of acute rejection or calcineurin inhibitor toxicity. The immunosuppressive regimen consisted of prednisolone (10 mg/day) and cyclosporine A (200 mg/day) throughout. The antihypertensive treatment comprised furosemide, beta blockers, and angiotensin-converting enzyme inhibitor. White blood count was reduced to 1.83/nL consisting of 76% neutrophilic granulocytes, 11% lymphocytes, 13% monocytes, 0% eosinophilic granulocytes, and 0% basophilic granulocytes. Platelet count was reduced to 70/nL and hemoglobin was reduced to 7.0 g/dL. The clinical evaluation of the skin, head and neck, heart and lung, abdomen, including the side of transplantation and the neurological status showed no pathological findings. Kidney function was stable with creatinine values of 400 μmol/L. Urinalysis did not show urinary tract infection. Blood cultures were negative. Ultrasound of the transplanted kidney showed no pathologic findings. A computed tomography of thorax and abdomen did not show pathological findings, except enlargement of the spleen of 15 cm. Lymph node enlargement was not observed. Transesophageal echocardiography did not show signs of endocarditis. A bronchoalveolar lavage excluded pneumocystis carinii, mycobacteria, or legionellae, and the patient was tested negative for human immunodeficiency virus and hepatitis. Screening for cytomegalovirus was negative, whereas polymerase chain reaction for Epstein-Barr virus was slightly positive. A bone marrow aspirate showed mainly myeloid cells with enhanced expression of cluster of differentiation 13 (CD 13), representing an early granulocytic antigen. On the other hand, CD 33, an antigen of myeloid progenitor cells, was observed in only 3%. The stem cell factor receptor ckit, a marker of immature blast cells, was enhanced and could be detected in 4% of cells. A cytogenetic analysis showed no structural or clonal numerical chromosomal aberrations. The cytological picture showed an extensive megakaryopoiesis with a shift to early cell stages and partially atypical nuclei (Fig. 1) . Staining showed an excess of stored iron. The erythropoiesis/granulopoiesis (E/G) ratio was markedly shifted in favor of granulopoiesis. All specimens showed a population of megakaryocytic blast cells. Cytology of the bone marrow aspirate showed acute AML FAB-M7. Because the patient was severely disabled, A. Scholze : M. Tepel (*)
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A wide variety of causes are considered when fever occurs in a patient after renal transplantation. The most common causes are viral, bacterial or opportunistic infections, transplant at rejection, side effects of new medications, or malignancies [1] . It appears that AML does develop more frequently after transplantation than in the normal population [2] [3] [4] . The incidence of AML after solid organ transplantations is about 0.2-2.5%. Post-transplant AML seems to develop after a median interval of 5 years (range 1-17 years). It is heterogeneous with respect to FAB classification and may show chromosomal and molecular changes [4] . However, the present case shows that AML FAB-M7 may develop as treatment-related without carrying multiple chromosomal aberrations. 
